الابحاث

South Egypt Cancer Institute

Assiut University

Department of Pediatric Oncology
# Title Research Member Research Year
81 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom Dr. Samar Muhammad mansour 2018
82 Flowcytometric CD135 Expression
and its Impact on Pediatric Acute
Lymphoblastic Leukemia at South Egypt
Cancer Institute 		Prof. Heba Abdel-Razik Sayed Hussein 2018
83 Acute Complications After High-Dose Chemotherapy and Stem-Cell Rescue in Pediatric Patients With High-Risk Neuroblastoma Treated in Countries With Different Resources Dr. Khaled Fathy Riad Osman 2018
84 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom Dr. Shaimaa / Elsayyed Youssef / Ahmed 2018
85 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom
 		Prof. Amany Mohamed Ali Ahmed 2018
86 Can Pediatric Risk of Mortality Score (PRISM III) Be Used Effectively in Initial Evaluation and Follow-up of Critically Ill Cancer Patients Admitted to Pediatric Oncology Intensive Care Unit (POICU)? A Prospective Study, in a Tertiary Cancer Center in Egy Prof. Amany Mohamed Ali Ahmed 2017
87 Environmentally-Mediated Epigenetic Effects: Uncovering the Fertile Soil in the Development of Pediatric Cancer Ameer Mohammed Abuelgheet Mohammed 2017
88 Evaluation of Surgical Methods for Treatment of Cubital Tunnel Syndrome – Statistical Perspectives Dr. Ahmed Mohammed Morsy Hassan 2017
89 Can Pediatric Risk of Mortality Score (PRISM III) Be Used Effectively in Initial Evaluation and Follow-up of Critically Ill Cancer Patients Admitted to Pediatric Oncology Intensive Care Unit (POICU)? A Prospective Study, in a Tertiary Cancer Center in Egy Mahmoud Motaz Elzembely 2017
90 Environmentally-Mediated Epigenetic Effects: Uncovering the Fertile Soil in the Development of Pediatric Cancer Ahmed Salaheldeen Hassan 2017